Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

FDA grants fast track designation for KB-103

May 25, 2018

Pfizer studies PF-06763809 in phase I trial for chronic plaque psoriasis

May 23, 2018

Nuclear receptor ROR-gamma inverse agonists disclosed by Escalier Biosciences

May 23, 2018

First patient enrolled in phase II study of MABp1 in atopic dermatitis

May 23, 2018

First-in-human study shows promise of SYNT-001 in pemphigus

May 22, 2018

FDA awards rare pediatric disease designation to CCP-020

May 17, 2018

Pivotal study of Dupixent in moderate to severe atopic dermatitis in adolescents meets key endpoints

May 16, 2018

First patient dosed in the phase I/II trial of KB-103

May 11, 2018

FDA approves IND for female hair loss trial of Histogen's HSC-660

May 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...